Jurgens, Sean J. http://orcid.org/0000-0002-1605-9782
Pirruccello, James P.
Choi, Seung Hoan http://orcid.org/0000-0002-2797-3190
Morrill, Valerie N.
Chaffin, Mark http://orcid.org/0000-0002-1234-5562
Lubitz, Steven A. http://orcid.org/0000-0002-9599-4866
Lunetta, Kathryn L. http://orcid.org/0000-0002-9268-810X
Ellinor, Patrick T. http://orcid.org/0000-0002-2067-0533
Funding for this research was provided by:
Foundation for the National Institutes of Health (1R01HL092577, 5RO1HL139731, 1R01HL157635, 5K08HL159346, R01HL149352, R01HL111024, 2R01HL127564-05A1, 1U01 AG058589-01A1, 1U01AG068221-01A1, 1R01HL164824-01, 1R01HL139731)
American Heart Association (18SFRN34110082, 18SFRN34250007)
European Union MAESTRIA
Hartstichting (03-007-2022-0035)
Amsterdam UMC Doctoral Fellowship
John S. LaDue Memorial Fellowship for Cardiovascular Research
BioData Ecosystem Fellowship program
Article History
Received: 11 October 2021
Accepted: 22 February 2023
First Online: 23 March 2023
Competing interests
: P.T.E. has received sponsored research support from Bayer AG, IBM Health, Bristol Myers Squibb and Pfizer; he has consulted for Bayer AG, Novartis and MyoKardia. S.A.L. is a full-time employee of Novartis Institutes of BioMedical Research as of 18 July 2022. S.A.L. previously received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier and IBM, and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences and Invitae. The remaining authors declare no competing interests.